

House
File
2044
-
Introduced


HOUSE
FILE
2044


BY
KAUFMANN


A
BILL
FOR


An
Act
relating
to
the
maintenance
and
administration
of
1


epinephrine
in
schools
and
certain
service
providers
2


regulated
by
the
department
of
human
services.
3


BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
4


TLSB
5147YH
(3)
85


je/nh



H.F.
2044


Section
1.
NEW
SECTION
.
217.37
Epinephrine
auto-injector
1


supply.
2


1.
For
purposes
of
this
section,
unless
the
context
3


otherwise
requires:
4


a.
“Epinephrine
auto-injector”
means
the
same
as
provided
5


in
section
280.16.
6


b.
“Personnel
authorized
to
administer
epinephrine”
means
an
7


employee
of
a
provider
trained
and
authorized
to
administer
an
8


epinephrine
auto-injector.
9


c.
“Physician”
means
the
same
as
provided
in
section
280.16.
10


d.
“Provider”
means
a
person
who
is
a
service
provider
who
11


is
registered,
approved,
licensed,
or
regulated
in
accordance
12


with
rules
adopted
by
the
department
of
human
services
or
who
13


is
reimbursed
in
whole
or
in
part
with
funding
administered
by
14


the
department.
“Provider”
includes
but
is
not
limited
to
a
15


child
care
provider,
a
family
or
group
foster
care
provider,
16


a
shelter
care
provider,
a
hospital,
a
mental
health
or
17


substance-related
disorder
service
provider,
an
institutional
18


or
home
and
community-based
services
waiver
provider
or
other
19


health
care
provider
that
receives
Medicaid
funding,
a
regional
20


mental
health
and
disability
service
system,
or
a
state
21


institution
administered
by
the
department.
22


2.
Notwithstanding
any
other
provision
of
law
to
the
23


contrary,
a
physician
may
prescribe
epinephrine
auto-injectors
24


in
the
name
of
a
provider
to
be
maintained
for
use
as
provided
25


in
this
section.
26


3.
A
provider
may
obtain
a
prescription
for
epinephrine
27


auto-injectors
and
maintain
a
supply
of
such
auto-injectors
28


in
a
secure
location
at
each
location
where
an
individual
29


receives,
treatment,
care,
or
supervision
from
the
provider
30


for
use
as
provided
in
this
section.
A
provider
who
obtains
31


such
a
prescription
shall
replace
epinephrine
auto-injectors
32


in
the
supply
upon
use
or
expiration.
Personnel
authorized
to
33


administer
epinephrine
may
possess
and
administer
epinephrine
34


auto-injectors
from
the
supply
as
provided
in
this
section.
35


-1-


LSB
5147YH
(3)
85


je/nh


1/
9




H.F.
2044


4.
Personnel
authorized
to
administer
epinephrine
may
1


provide
or
administer
an
epinephrine
auto-injector
from
the
2


provider’s
supply
to
an
individual
under
the
treatment,
care,
3


or
supervision
of
the
provider
if
such
personnel
reasonably
and
4


in
good
faith
believe
the
individual
is
having
an
anaphylactic
5


reaction.
6


5.
Any
personnel
authorized
to
administer
epinephrine
7


who
provide,
administer,
or
assist
in
the
administration
8


of
an
epinephrine
auto-injector
to
an
individual
receiving
9


treatment,
care,
or
supervision
from
the
provider
who
such
10


personnel
reasonably
and
in
good
faith
believe
to
be
having
an
11


anaphylactic
reaction;
a
provider
employing
the
personnel;
the
12


owner
or
operator
of
the
provider;
or
the
prescriber
of
the
13


epinephrine
auto-injector,
shall
incur
no
liability,
except
for
14


gross
negligence,
as
a
result
of
any
injury
arising
from
the
15


provision,
administration,
or
assistance
in
the
administration
16


of
an
epinephrine
auto-injector
as
provided
in
this
section.
17


6.
The
department
of
human
services,
the
board
of
medicine,
18


and
the
board
of
pharmacy
shall
adopt
rules
to
implement
and
19


administer
this
section,
including
but
not
limited
to
standards
20


and
procedures
for
the
prescription,
distribution,
storage,
21


replacement,
and
administration
of
epinephrine
auto-injectors,
22


and
for
training
and
authorization
to
be
required
for
personnel
23


authorized
to
administer
epinephrine.
24


Sec.
2.
Section
280.16,
Code
2014,
is
amended
to
read
as
25


follows:
26


280.16
Self-administration
of
asthma
or
other
airway


27


constricting
disease
medication
certain
medications
.
28


1.
Definitions.
For
purposes
of
this
section
:
29


a.
“Epinephrine
auto-injector”
means
a
medical
device
for
30


immediate
self-administration
of
a
measured
dose
of
epinephrine


31


by
a
person
at
risk
of
anaphylaxis.


32


a.


b.
“Medication”
means
a
drug
that
meets
the
definition
33


provided
in
section
126.2,
subsection
8
,
has
an
individual
34


prescription
label,
is
prescribed
by
a
physician
for
a
35


-2-


LSB
5147YH
(3)
85


je/nh


2/
9














H.F.
2044


student,
and
pertains
to
the
student’s
asthma
or
other
airway
1


constricting
disease.
2


b.


c.
“Physician”
means
a
person
licensed
under
chapter
3


148
,
or
a
physician’s
assistant,
advanced
registered
nurse
4


practitioner,
or
other
person
licensed
or
registered
to
5


distribute
or
dispense
a
prescription
drug
or
device
in
the
6


course
of
professional
practice
in
this
state
in
accordance
7


with
section
147.107
,
or
a
person
licensed
by
another
state
8


in
a
health
field
in
which,
under
Iowa
law,
licensees
in
this
9


state
may
legally
prescribe
drugs.
10


c.
d.
“Self-administration”
means
a
student’s
discretionary
11


use
of
medication
prescribed
by
a
physician
for
the
student.
12


2.
The
board
of
directors
of
a
school
district
and
the
13


authorities
in
charge
of
an
accredited
nonpublic
school
shall
14


permit
the
self-administration
of
medication
by
a
student
15


with
asthma
or
other
airway
constricting
disease
or
the
use
16


of
an
epinephrine
auto-injector
by
a
student


if
the
following
17


conditions
are
met:
18


a.
The
student’s
parent
or
guardian
provides
to
the
school
19


written
authorization
for
the
self-administration
of
medication
20


or
for
the
use
of
an
epinephrine
auto-injector


.
21


b.
The
student’s
parent
or
guardian
provides
to
the
school
22


a
written
statement
from
the
student’s
physician
containing
the
23


following
information:
24


(1)
The
name
and
purpose
of
the
medication
or
epinephrine


25


auto-injector


.
26


(2)
The
prescribed
dosage.
27


(3)
The
times
at
which
or
the
special
circumstances
under
28


which
the
medication
or
epinephrine
auto-injector
is
to
be
29


administered.
30


c.
The
parent
or
guardian
and
the
school
meet
the
31


requirements
of
subsection
3
.
32


3.
The
school
district
or
accredited
nonpublic
school
33


shall
notify
the
parent
or
guardian
of
the
student,
in
34


writing,
that
the
school
district
or
accredited
nonpublic
35


-3-


LSB
5147YH
(3)
85


je/nh


3/
9













H.F.
2044


school
and
its
employees
are
to
incur
no
liability,
except
1


for
gross
negligence,
as
a
result
of
any
injury
arising
from
2


self-administration
of
medication
or
use
of
an
epinephrine


3


auto-injector
by
the
student.
The
parent
or
guardian
of
the
4


student
shall
sign
a
statement
acknowledging
that
the
school
5


district
or
nonpublic
school
is
to
incur
no
liability,
except
6


for
gross
negligence,
as
a
result
of
self-administration
of
7


medication
or
use
of
an
epinephrine
auto-injector
by
the
8


student.
A
school
district
or
accredited
nonpublic
school
9


and
its
employees
acting
reasonably
and
in
good
faith
shall
10


incur
no
liability
for
any
improper
use
of
medication
or
an
11


epinephrine
auto-injector
as
defined
in
this
section
or
for
12


supervising,
monitoring,
or
interfering
with
a
student’s
13


self-administration
of
medication
or
use
of
an
epinephrine
14


auto-injector
as
defined
in
this
section
.
15


4.
The
permission
for
self-administration
of
medication
16


or
use
of
an
epinephrine
auto-injector


is
effective
for
the
17


school
year
for
which
it
is
granted
and
shall
be
renewed
each
18


subsequent
school
year
upon
fulfillment
of
the
requirements
19


of
this
section
.
However,
the
parent
or
guardian
shall
20


immediately
notify
the
school
of
any
changes
in
the
conditions
21


listed
under
subsection
2
.
22


5.
Provided
that
the
requirements
of
this
section
are
23


fulfilled,
a
student
with
asthma
or
other
airway
constricting
24


disease
may
possess
and
use
the
student’s
medication
and
a


25


student
with
a
written
statement
from
a
physician
on
file


26


pursuant
to
subsection
2,
paragraph
“a”
may
use
an
epinephrine
27


auto-injector
while
in
school,
at
school-sponsored
activities,
28


under
the
supervision
of
school
personnel,
and
before
or
after
29


normal
school
activities,
such
as
while
in
before-school
or
30


after-school
care
on
school-operated
property.
If
the
student
31


misuses
this
privilege,
the
privilege
may
be
withdrawn.
A


32


school
district
or
nonpublic
school
shall
notify
a
student’s


33


parent
or
guardian
before
withdrawing
the
privilege
to
use
an


34


epinephrine
auto-injector.


35


-4-


LSB
5147YH
(3)
85


je/nh


4/
9





















H.F.
2044


6.
Information
provided
to
the
school
under
subsection
2
1


shall
be
kept
on
file
in
the
office
of
the
school
nurse
or,
in
2


the
absence
of
a
school
nurse,
the
school’s
administrator.
3


7.
The
Iowa
braille
and
sight
saving
school,
the
state
4


school
for
the
deaf,
and
the
institutions
under
the
control
of
5


the
department
of
human
services
as
provided
in
section
218.1
6


are
exempt
from
the
provisions
of
this
section
.
7


Sec.
3.
NEW
SECTION


.
280.16A
Epinephrine
auto-injector
8


supply.
9


1.
For
purposes
of
this
section,
unless
the
context
10


otherwise
requires:
11


a.
“Epinephrine
auto-injector”
means
the
same
as
provided
12


in
section
280.16.
13


b.
“Personnel
authorized
to
administer
epinephrine”
means
a
14


school
nurse
or
other
employee
of
a
school
district
trained
and
15


authorized
to
administer
an
epinephrine
auto-injector.
16


c.
“Physician”
means
the
same
as
provided
in
section
280.16.
17


2.
Notwithstanding
any
other
provision
of
law
to
the
18


contrary,
a
physician
may
prescribe
epinephrine
auto-injectors
19


in
the
name
of
a
school
district
to
be
maintained
for
use
as
20


provided
in
this
section.
21


3.
The
board
of
directors
in
charge
of
each
school
district
22


shall
obtain
a
prescription
for
epinephrine
auto-injectors
and
23


maintain
a
supply
of
such
auto-injectors
in
a
secure
location
24


at
each
school
for
use
as
provided
in
this
section.
The
board
25


shall
replace
epinephrine
auto-injectors
in
the
supply
upon
use
26


or
expiration.
Personnel
authorized
to
administer
epinephrine
27


may
possess
and
administer
epinephrine
auto-injectors
from
the
28


supply
as
provided
in
this
section.
29


4.
Personnel
authorized
to
administer
epinephrine
may
30


provide
or
administer
an
epinephrine
auto-injector
from
31


the
school
district’s
supply
to
a
student
if
such
personnel
32


reasonably
and
in
good
faith
believe
the
student
is
having
an
33


anaphylactic
reaction.
34


5.
Any
personnel
authorized
to
administer
epinephrine
35


-5-


LSB
5147YH
(3)
85


je/nh


5/
9




H.F.
2044


who
provide,
administer,
or
assist
in
the
administration
1


of
an
epinephrine
auto-injector
to
a
student
who
such
2


personnel
reasonably
and
in
good
faith
believe
to
be
having
3


an
anaphylactic
reaction;
a
school
district
employing
the
4


personnel;
the
board
of
directors
in
charge
of
the
school
5


district;
or
the
prescriber
of
the
epinephrine
auto-injector,
6


shall
incur
no
liability,
except
for
gross
negligence,
7


as
a
result
of
any
injury
arising
from
the
provision,
8


administration,
or
assistance
in
the
administration
of
an
9


epinephrine
auto-injector
as
provided
in
this
section.
10


6.
The
department
of
education,
the
board
of
medicine,
11


and
the
board
of
pharmacy
shall
adopt
rules
to
implement
and
12


administer
this
section,
including
but
not
limited
to
standards
13


and
procedures
for
the
prescription,
distribution,
storage,
14


replacement,
and
administration
of
epinephrine
auto-injectors,
15


and
for
training
and
authorization
to
be
required
for
personnel
16


authorized
to
administer
epinephrine.
17


Sec.
4.
POLICIES
ON
ANAPHYLAXIS
IN
A
SCHOOL
SETTING.
The
18


department
of
education
shall
develop,
in
collaboration
19


with
the
board
of
medicine
and
education
and
health
care
20


stakeholders,
policies
for
the
recognition
and
treatment
21


of
anaphylaxis
in
a
school
setting.
The
director
of
the
22


department
shall
submit
a
report
to
the
general
assembly
by
23


January
1,
2015,
recommending
any
legislation
necessary
to
24


improve
recognition
and
treatment
of
anaphylaxis
in
a
school
25


setting.
26


Sec.
5.
IMPLEMENTATION
OF
ACT.
Section
25B.2,
subsection
27


3,
shall
not
apply
to
this
Act.
28


EXPLANATION
29


The
inclusion
of
this
explanation
does
not
constitute
agreement
with
30


the
explanation’s
substance
by
the
members
of
the
general
assembly.
31


This
bill
requires
the
board
of
directors
in
charge
of
each
32


school
district
to
maintain
in
a
secure
location
at
each
school
33


a
supply
of
epinephrine
auto-injectors
for
use
as
provided
in
34


the
bill.
The
bill
requires
the
board
to
replace
epinephrine
35


-6-


LSB
5147YH
(3)
85


je/nh


6/
9



H.F.
2044


auto-injectors
in
the
supply
upon
use
or
expiration.
The
bill
1


requires
the
board
to
obtain
a
prescription
for
epinephrine
2


auto-injectors
for
use
as
provided
in
the
bill.
The
bill
3


permits
personnel
authorized
to
administer
epinephrine
to
4


possess
and
administer
epinephrine
auto-injectors
from
the
5


supply
as
provided
in
the
bill.
The
bill
permits
a
physician
6


to
prescribe
epinephrine
auto-injectors
in
the
name
of
a
school
7


district
to
be
maintained
for
use
as
provided
in
the
bill,
8


notwithstanding
any
other
provision
of
law
to
the
contrary.
9


The
bill
permits
personnel
authorized
to
administer
10


epinephrine
to
provide
or
administer
an
epinephrine
11


auto-injector
from
a
school
district’s
supply
to
a
student
if
12


such
personnel
reasonably
and
in
good
faith
believe
the
student
13


is
having
an
anaphylactic
reaction.
14


The
bill
provides
immunity
from
legal
liability,
except
for
15


gross
negligence,
to
any
personnel
authorized
to
administer
16


epinephrine
who
provide,
administer,
or
assist
in
the
17


administration
of
an
epinephrine
auto-injector
to
a
student
18


who
such
personnel
reasonably
and
in
good
faith
believe
to
be
19


having
an
anaphylactic
reaction;
a
school
district
employing
20


the
personnel;
the
board
of
directors
in
charge
of
the
school
21


district;
or
the
prescriber
of
the
epinephrine
auto-injector,
22


for
any
injury
arising
from
the
provision,
administration,
23


or
assistance
in
the
administration
of
an
epinephrine
24


auto-injector
as
provided
in
the
bill.
25


The
bill
defines
“epinephrine
auto-injector”
as
a
medical
26


device
for
immediate
self-administration
of
a
measured
dose
27


of
epinephrine
by
a
person
at
risk
of
anaphylaxis.
The
bill
28


defines
“personnel
authorized
to
administer
epinephrine”
as
an
29


employee
trained
and
authorized
to
administer
an
epinephrine
30


auto-injector.
31


The
bill
permits
a
person
who
is
a
service
provider
who
is
32


registered,
approved,
licensed,
or
regulated
in
accordance
33


with
rules
adopted
by
the
department
of
human
services
or
who
34


is
reimbursed
in
whole
or
in
part
with
funding
administered
35


-7-


LSB
5147YH
(3)
85


je/nh


7/
9



H.F.
2044


by
the
department
to
maintain
a
supply
of
epinephrine
1


auto-injectors
in
the
same
fashion,
with
the
same
duties,
2


powers,
and
immunities
relating
to
maintaining
a
supply
of
3


epinephrine
auto-injectors
and
administering
the
auto-injectors
4


applying
if
the
provider
chooses
to
do
so.
The
bill
specifies
5


that
“provider”
includes
but
is
not
limited
to
a
child
care
6


provider,
a
family
or
group
foster
care
provider,
a
shelter
7


care
provider,
a
hospital,
a
mental
health
or
substance-related
8


disorder
service
provider,
an
institutional
or
home
and
9


community-based
services
waiver
provider
or
other
health
care
10


provider
that
receives
Medicaid
funding,
a
regional
mental
11


health
and
disability
service
system,
or
a
state
institution
12


administered
by
the
department.
13


The
bill
requires
the
department
of
education,
the
14


department
of
human
services,
the
board
of
medicine,
and
the
15


board
of
pharmacy
to
adopt
rules
to
implement
and
administer
16


the
bill,
including
but
not
limited
to
standards
and
procedures
17


for
the
prescription,
distribution,
storage,
replacement,
and
18


administration
of
epinephrine
auto-injectors,
and
for
training
19


and
authorization
to
be
required
for
personnel
authorized
to
20


administer
epinephrine
auto-injectors.
21


The
bill
also
adds
epinephrine
auto-injectors
to
Code
22


section
280.16,
which
permits
self-administration
of
medication
23


in
public
and
nonpublic
schools
by
students
with
asthma.
24


The
bill
requires
school
districts
and
nonpublic
schools
25


to
allow
the
use
of
an
epinephrine
auto-injector
by
a
student
26


with
a
written
statement
from
a
physician
on
file
if
the
school
27


receives
written
authorization
and
certain
medical
information
28


from
the
student’s
parent
or
guardian.
29


The
bill
permits
a
student
with
a
written
statement
30


from
a
physician
on
file
to
possess
and
use
an
epinephrine
31


auto-injector
while
in
school,
at
school-sponsored
activities,
32


under
the
supervision
of
school
personnel,
and
before
or
after
33


normal
school
activities,
such
as
while
in
before-school
or
34


after-school
care
on
school-operated
property.
The
bill
35


-8-


LSB
5147YH
(3)
85


je/nh


8/
9



H.F.
2044


requires
a
school
district
or
nonpublic
school
to
notify
a
1


student’s
parent
or
guardian
before
withdrawing
the
privilege
2


to
use
an
epinephrine
auto-injector.
3


The
bill
adds
epinephrine
auto-injectors
to
the
provisions
4


of
Code
section
280.16
granting
immunity
from
legal
liability
5


to
school
employees,
except
for
gross
negligence,
for
injuries
6


resulting
from
the
self-administration
of
medication.
Code
7


section
280.16
requires
a
student’s
parent
or
guardian
to
8


receive
notice
of
such
immunity.
9


The
bill
requires
the
director
of
the
department
of
10


education
to
develop,
in
collaboration
with
the
board
of
11


medicine
and
education
and
health
care
stakeholders,
policies
12


for
the
recognition
and
treatment
of
anaphylaxis
in
a
school
13


setting.
The
bill
requires
the
director
to
submit
a
report
14


to
the
general
assembly
by
January
1,
2015,
recommending
any
15


legislation
necessary
to
improve
recognition
and
treatment
of
16


anaphylaxis
in
a
school
setting.
17


The
bill
may
include
a
state
mandate
as
defined
in
Code
18


section
25B.3.
The
bill
makes
inapplicable
Code
section
25B.2,
19


subsection
3,
which
would
relieve
a
political
subdivision
from
20


complying
with
a
state
mandate
if
funding
for
the
cost
of
21


the
state
mandate
is
not
provided
or
specified.
Therefore,
22


political
subdivisions
are
required
to
comply
with
any
state
23


mandate
included
in
the
bill.


24


-9-


LSB
5147YH
(3)
85


je/nh


9/
9

